Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobeglitazone vs linagliptin add-on to metformin + empagliflozin in type 2 diabetes
KCT0004509Phase 3Completed
- Sponsor
- Chong Kun Dang
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Lobeglitazone add-on arm with Linagliptin add-on arm (2 arms). Started Oct 2020; status: completed.
02
Drugs
lobeglitazonelinagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0004509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004509.